Xtl Biopharmaceuticals (XTLB) Beginning Cash Balance (2010 - 2011)

Xtl Biopharmaceuticals (XTLB) posted quarterly Beginning Cash Balance of -$757000.0 for Q4 2011, down 12516.67% year-on-year from N/an in Q4 2010, and down 395.7% on a QoQ basis from $256000.0 in Q3 2011.

Xtl Biopharmaceuticals (XTLB) Beginning Cash Balance (2010 - 2011) Analysis & Trends

Xtl Biopharmaceuticals (XTLB) has reported Beginning Cash Balance for 2 consecutive years, with -$757000.0 the latest figure, recorded in Q4 2011.

  • Quarterly Beginning Cash Balance fell 12516.67% year-over-year to -$757000.0 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $71000.0 (changed N/A YoY) and the FY2025 annual result came in at $371000.0, down 73.52% from the prior year.
  • Beginning Cash Balance eased to -$757000.0 in Q4 2011 per XTLB's latest filing, from $256000.0 in the prior quarter.
  • Over the last five years, Beginning Cash Balance for XTLB reached as high as $578000.0 in Q2 2011 and fell as low as -$757000.0 in Q4 2011.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Xtl Biopharmaceuticals 2.60 Bn 2.60 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2011 -757,000.00
Dec 31, 2011 -757,000.00
Sep 30, 2011 256,000.00
Sep 30, 2011 256,000.00
Jun 30, 2011 578,000.00
Jun 30, 2011 578,000.00
Dec 31, 2010 -6,000.00
Dec 31, 2010 -6,000.00
Sep 30, 2010 137,000.00
Sep 30, 2010 137,000.00
Jun 30, 2010 251,000.00
Jun 30, 2010 251,000.00